C ardiac electrophysiology is a field with a rich history of integrative modeling that has been coupled closely with design and interpretation of experiments. The first models of the cardiac action potential (AP) 1 were developed shortly after the Hodgkin-Huxley model of the squid AP and were formulated to explain the experimental observation that, unlike neuronal APs, cardiac APs exhibit a long duration plateau phase. Over the subsequent 20 years, refinement of these models to incorporate emerging experimental data on properties of voltage-gated membrane currents, transport and exchange processes regulating intracellular ion concentrations, and mechanisms of calcium (Ca 2ϩ )induced Ca 2ϩ -release (CICR) led to the first integrative model of the cardiac AP, the DiFrancesco-Noble model. 2 This landmark model of the Purkinje fiber AP provided the electrophysiological community a mathematical framework on which to build, thus stimulating development of a broad range of integrative cardiac myocyte models. These now include models of canine, guinea pig, human and rabbit ventricular myocytes, 3-8 sinoatrial node cells (for review, see Wilders et al 9 ) and atrial myocytes. 10, 11 Recent research efforts have been directed at extending the range of biophysical and biochemical mechanisms included in these models to enhance their explanatory and predictive capabilities. Important areas of research include: (1) use of single-channel and whole cell current data, in combination with knowledge of channel protein structure, to develop continuous time Markov chain models of voltage-gated channels and membrane transporters 12,13 ; (2) development and integration of mechanistic models of the CICR process 12,14,15 ; (3) modeling of force generation 16 ; (4) modeling of mitochondrial ATP production and its regulation by Ca 2ϩ 17 ; and (5) the first steps toward incorporation of intracellular signaling pathways and their actions on target proteins. 18 With this depth of mechanistic detail, it is fair to say that if there is a "virtual" cell to be had, it is the cardiac myocyte.
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Applications of these myocyte models have been both diverse and informative. More detailed characterization of channel gating properties has enabled investigation of the arrhythmogenic potential of "channelopathies" at the cellular level. 13, 19 Models have also been applied to analyzing the potential benefits of targeted gene delivery for regulation of QT interval. 20 Incorporation of changes in the expression levels of potassium (K ϩ ) channels and Ca 2ϩ cycling proteins measured experimentally in end-stage heart failure within a model of the canine ventricular myocyte has accounted for observed changes of the heart failure phenotype, including AP prolongation and reduction of Ca 2ϩ transient amplitude. 4 Modeling the effects of acute ischemia (elevated extracellular K ϩ levels, acidosis, and anoxia) has provided insight into mechanisms of slowed and failing conduction. 21 Further integration is of course required to understand how disease-induced changes in cellular processes affect function at the level of tissue and whole organ. In this regard, a second landmark study was that of Nielsen et al. 22 These investigators were the first to develop experimental methods for the systematic reconstruction of cardiac ventricular fiber organization and efficient computational methods for the representation of these anatomical data through use of finiteelement models. 22 This important development set the stage for modeling of electrical conduction in cardiac ventricular tissue and whole-ventricles through solution of either the bidomain or monodomain reaction-diffusion equations. 23 Subsequent development of diffusion tensor MRI methods to map ventricular fiber organization has both improved the spatial resolution as well as decreased the time needed to acquire data on ventricular geometry and fiber structure. 24 This brings us to the elegant study of Saucerman et al, presented in this issue of Circulation Research. 25 These investigators capitalize on both of the integrative modeling approaches described above to elucidate a mechanistic link between a mutation in KCNQ1, the gene that encodes the ␣ subunit of the repolarizing current I Ks and the abnormal electrocardiogram associated with long QT syndrome. The LQT1associated mutation KCNQ1-G589D has been found to disrupt a local signaling complex composed of the A-kinase anchoring protein (AKAP) yotiao, KCNQ1, protein kinase A (PKA), and protein phosphatase 1, 26 and LQT1 patients display additional QT prolongation and increased susceptibility to sudden cardiac death 27 in response to exercise or stress. Because this mutation leads to a defect at the interface between the ␤ 1 -adrenergic signaling cascade and a target membrane current protein, a theoretical study of the underlying mechanisms could only be accomplished with a model that incorporates both cell signaling and electrophysiology and is then extended to the tissue level. Saucerman et al 25 therefore develop and apply a rather comprehensive integrative computational model of ␤ 1 -adrenergic signaling, excitation-contraction coupling, and AP propagation to dissect the mechanisms underlying the LQT1 clinical phenotype in patients with the KCNQ1-G589D mutation. The findings indicate that the KCNQ1-G589D mutation alone does not prolong the QT interval, but that in the presence of the ␤-adrenergic agonist isoproterenol, abnormalities of repolarization occur in the form of early afterdepolarizations (EADs), and QT prolongation. Prolongation is a consequence of enhanced L-type Ca 2ϩ current in the absence of a counterbalancing enhancement of I Ks . Analysis of conduction using a 3-D ventricular wedge model shows that the occurrence of early afterdepolarizations elevates transmural dispersion of repolarization and leads to additional T-wave. The authors conclude that the KCNQ1-G589D mutation causes a breakdown in the regulatory control of I Ks by the b 1 -adrenergic signaling pathway, yielding an increase in the occurrence of repolarization abnormalities, increased dispersion of repolarization in the ventricular wedge and increased vulnerability to abnormal impulse propagation.
The integrative modeling achieved by Saucerman et al has clearly enhanced our understanding of mechanisms of arrhythmia at the cell and tissue level. However, even greater levels of integrative understanding remain to be confronted. One of the most important involves local signaling complexes within the myocyte. The fact that AKAP yotiao, KCNQ1, PKA, and phosphatase 1 coimmunoprecipitate 26 suggests that signaling occurs within a small microdomain near this complex. Another clear example of such microdomain signaling is the process of cardiac CICR. Given estimates of diad dimensions, protein size and placement, and the concentration changes likely to occur in response to Ca 2ϩ release events, signaling between the L-Type Ca 2ϩ channel and ryanodine receptors is likely mediated by fewer than Ϸ10 free Ca 2ϩ ions. Evidence from neurons suggests that in the case of the ␤ 2 -adrenergic signaling system, the receptor, G protein, L-Type Ca 2ϩ channel, adenylyl cyclase, AKAP, PKA and protein phosphatase 2A coimmunoprecipitate, 28 a finding likely true of cardiac myocytes. Reaction-diffusion equations derived from laws of mass action are not appropriate for describing concentrations of signaling molecules at these anticipated low molecule counts. Rather, in this situation, the stochastic motion of molecules is likely to have a profound effect on the nature of local signaling 29 and potentially of cell and tissue behavior as well. Understanding and modeling of these molecular-level events, as well as development of new mathematical approaches for abstracting models across multiple levels of biological analysis, remains an important challenge for the future.
